22157.jpg
Global Menopause Market Size, Share & Trends Analysis Report 2024 - A USD 24.4 Billion Market by 2030 with a Robust CAGR of 5.37%
19 mars 2024 12h35 HE | Research and Markets
Dublin, March 19, 2024 (GLOBE NEWSWIRE) -- The "Global Menopause Market Size, Share & Trends Analysis Report by Treatment (Dietary Supplements, OTC Pharma Products), Region (North America,...
Global Menopausal Therapy Market
Global Menopausal Therapy Market Report 2024-2034: Dietary Supplements Dominate 2023 Revenue with Natural Product Surge; OTC Pharma Products Poised for Fastest Growth
24 janv. 2024 14h28 HE | Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Menopausal Therapy Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. The global...
Global Menopausal Hot Flashes Market
Global Menopausal Hot Flashes Market: Growth in Non-Hormonal Treatments and use of Online Pharmacies
05 janv. 2024 21h58 HE | Research and Markets
Dublin, Jan. 05, 2024 (GLOBE NEWSWIRE) -- The "Global Menopausal Hot Flashes Market by Treatment Type (Alternative Treatment, Hormonal Treatment, Non-Hormonal Treatment), Distribution Channel...
22157.jpg
Unraveling the Future of the Menopause Market: Trends and Growth Forecasts to 2033
07 août 2023 04h08 HE | Research and Markets
Dublin, Aug. 07, 2023 (GLOBE NEWSWIRE) -- The "Menopause Market Report 2023-2033" has been added to ResearchAndMarkets.com's offering.This in-depth report provides valuable insights into the...
22157.jpg
Global Menopausal Hot Flashes Treatment Market Report 2023: Treatment Type, Industry Size, Shares, Trends, Opportunities, and Forecasts, 2018-2028F
10 mai 2023 10h53 HE | Research and Markets
Dublin, May 10, 2023 (GLOBE NEWSWIRE) -- The "Menopausal Hot Flashes Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented by Type (Oral Liquid v/s...
Novogen Signs Spanish Patent License With Laboratorios Casen-Fleet
23 juin 2008 08h00 HE | Novogen, Limited
STAMFORD, CT and SYDNEY, AUSTRALIA--(Marketwire - June 23, 2008) - Novogen Limited (ASX: NRT) (NASDAQ: NVGN), the registered owner of the European Patent "Use of isoflavone phyto-oestrogen extracts...